| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |